Skip to menu Skip to content Skip to footer

2020

Journal Article

Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: Case-control study

Abramson, Michael J., Murambadoro, Tsitsi, Alif, Sheikh M., Benke, Geza P., Dharmage, Shyamali C., Glaspole, Ian, Hopkins, Peter, Hoy, Ryan F., Klebe, Sonja, Moodley, Yuben, Rawson, Shuli, Reynolds, Paul N., Wolfe, Rory, Corte, Tamera J. and Haydn Walters, E. (2020). Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: Case-control study. Thorax, 75 (10), 864-869. doi: 10.1136/thoraxjnl-2019-214478

Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: Case-control study

2020

Journal Article

Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer

Green, Adele C., Way, Mandy, Oster, Mariella, Plasmeijer, Elsemieke I., Jiyad, Zainab, O’Rourke, Peter, Miura, Kyoko, Campbell, Scott, Isbel, Nicole, Chambers, Daniel C., Hopkins, Peter, Ferguson, Lisa E., Davis, Marcia Batista, Whiteman, David C., Soyer, H. Peter and Marquart, Louise (2020). Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer. Archives of Dermatological Research, 314 (2), 203-206. doi: 10.1007/s00403-020-02136-4

Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer

2020

Journal Article

Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis

Clynick, Britt, Jo, Helen E., Corte, Tamera J., Glaspole, Ian N., Grainge, Christopher, Hopkins, Peter M.A., Reynolds, Paul N., Chapman, Sally, Haydn Walters, E., Zappala, Christopher, Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, Goh, Nicole S., Baltic, Svetlana, Ryan, Marisa, Tan, Dino B.A. and Moodley, Yuben P. (2020). Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis. European Respiratory Journal, 56 (3) 1902058, 1-4. doi: 10.1183/13993003.02058-2019

Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis

2020

Conference Publication

A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation

Divithotawela, C., Pham, A., Ledger, E. L., Hopkins, P., Tan, M., Yerkovich, S., Wells, T. J. and Chambers, D. C. (2020). A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation. 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), Montreal, Canada, 22-25 April 2020. New York, NY United States: Elsevier.

A Novel Pseudomonas aeruginosa Virulence Factor Predicts CLAD and Death after Lung Transplantation

2020

Journal Article

Skin cancer multiplicity in lung transplant recipients: a prospective population‐based study

Way, M., Marquart, L., Chambers, D. C., Hopkins, P., Miura, K., Jiyad, Z., Plasmeijer, E. I., Ferguson, L. E., Davis, M., Whiteman, D. C., Soyer, H. P., O'Rourke, P. and Green, A. C. (2020). Skin cancer multiplicity in lung transplant recipients: a prospective population‐based study. British Journal of Dermatology, 183 (3) bjd.18812, 503-508. doi: 10.1111/bjd.18812

Skin cancer multiplicity in lung transplant recipients: a prospective population‐based study

2020

Journal Article

Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies

Divithotawela, Chandima, Pham, Amy, Ledger, Emma L., Hopkins, Peter, Wells, Timothy J. and Chambers, Daniel (2020). Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies. Journal of Heart and Lung Transplantation, 39 (1), 87-89. doi: 10.1016/j.healun.2019.10.001

Treatment of life-threatening Pseudomonas aeruginosa infection by pheresis of inhibitory antibodies

2019

Journal Article

Endothelial glycocalyx shedding predicts donor organ acceptability and is associated with primary graft dysfunction in lung transplant recipients

Sladden, Timothy M., Yerkovich, Stephanie, Grant, Michelle, Zhang, Fuming, Liu, Xinyue, Trotter, Michael, Hopkins, Peter, Linhardt, Robert J. and Chambers, Daniel C. (2019). Endothelial glycocalyx shedding predicts donor organ acceptability and is associated with primary graft dysfunction in lung transplant recipients. Transplantation, 103 (6), 1277-1285. doi: 10.1097/TP.0000000000002539

Endothelial glycocalyx shedding predicts donor organ acceptability and is associated with primary graft dysfunction in lung transplant recipients

2019

Journal Article

Gastroesophageal reflux and antacid therapy in IPF: Analysis from the Australia IPF Registry

Jo, Helen E., Corte, Tamera J., Glaspole, Ian, Grainge, Christopher, Hopkins, Peter M. A., Moodley, Yuben, Reynolds, Paul N., Chapman, Sally, Walters, E. Haydn, Zappala, Christopher, Allan, Heather, Keir, Gregory J., Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, MacAnsh, Sacha and Goh, Nicole S. (2019). Gastroesophageal reflux and antacid therapy in IPF: Analysis from the Australia IPF Registry. BMC Pulmonary Medicine, 19 (1) 84, 84. doi: 10.1186/s12890-019-0846-2

Gastroesophageal reflux and antacid therapy in IPF: Analysis from the Australia IPF Registry

2019

Journal Article

Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: experience of the Australian Lung Transplant Collaborative

Mackintosh, John A., Munsif, Maitri, Ranzenbacher, Lucy, Thomson, Claire, Musk, Michael, Snell, Gregory, Glanville, Allan, Chambers, Daniel C. and Hopkins, Peter (2019). Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: experience of the Australian Lung Transplant Collaborative. Journal of Heart and Lung Transplantation, 38 (5), 553-559. doi: 10.1016/j.healun.2019.02.005

Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: experience of the Australian Lung Transplant Collaborative

2019

Journal Article

Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing

Burgess, Andrew, Goon, Ken, Brannan, John D., Attia, John, Palazzi, Kerrin, Oldmeadow, Christopher, Corte, Tamera J., Glaspole, Ian, Goh, Nicole, Keir, Gregory, Allan, Heather, Chapman, Sally, Cooper, Wendy, Ellis, Samantha, Hopkins, Peter, Moodley, Yuben, Reynolds, Paul, Zappala, Chris, Macansh, Sacha and Grainge, Christopher (2019). Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing. Respirology, 24 (10) resp.13540, 988-995. doi: 10.1111/resp.13540

Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing

2018

Journal Article

Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial

Miura, Kyoko, Vail, Andy, Chambers, Daniel, Hopkins, Peter M., Ferguson, Lisa, Grant, Michelle, Rhodes, Lesley E. and Green, Adèle C. (2018). Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial. The Journal of Heart and Lung Transplantation, 38 (1), 59-65. doi: 10.1016/j.healun.2018.09.009

Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial

2018

Journal Article

Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial

Smith, Corey, Beagley, Leone, Rehan, Sweera, Neller, Michelle A., Crooks, Pauline, Solomon, Matthew, Holmes-Liew, Chien-Li, Holmes, Mark, McKenzie, Scott, Hopkins, Peter, Campbell, Scott, Francis, Ross, Chambers, Daniel and Khanna, Rajiv (2018). Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial. Clinical Infectious Diseases, 68 (4), 632-640. doi: 10.1093/cid/ciy549

Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant patients: a single-arm open-label phase I clinical trial

2018

Journal Article

Sarcopenia in lung transplant candidates: A novel biomarker to estimate skeletal muscle mass

Walsh, James R. and Hopkins, Peter M. A. (2018). Sarcopenia in lung transplant candidates: A novel biomarker to estimate skeletal muscle mass. Clinical Transplantation, 32 (3) e13200, 1-2. doi: 10.1111/ctr.13200

Sarcopenia in lung transplant candidates: A novel biomarker to estimate skeletal muscle mass

2018

Conference Publication

THE INTERSTITIAL LUNG DISEASE MULTI-DISCIPLINARY MEETING: 3 YEAR REVIEW OF A NOVEL STATEWIDE TELEMEDICINE MODEL

Balzat, L., Chamber, D., Godbolt, D., Reddy, T., Keir, G., Sivakumaran, S., Bint, M., Bancroft, S. and Hopkins, P. (2018). THE INTERSTITIAL LUNG DISEASE MULTI-DISCIPLINARY MEETING: 3 YEAR REVIEW OF A NOVEL STATEWIDE TELEMEDICINE MODEL. HOBOKEN: WILEY.

THE INTERSTITIAL LUNG DISEASE MULTI-DISCIPLINARY MEETING: 3 YEAR REVIEW OF A NOVEL STATEWIDE TELEMEDICINE MODEL

2018

Journal Article

Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary

Jo, Helen E., Prasad, Jyotika D., Troy, Lauren K, Mahar, Annabelle, Bleasel, Jane, Ellis, Samantha J., Chambers, Daniel C., Holland, Anne E., Lake, Fiona R., Keir, Gregory, Goh, Nicole S, Wilsher, Margaret, de Boer, Sally, Moodley, Yuben, Grainge, Christopher, Whitford, Helen M., Chapman, Sally A., Reynolds, Paul N., Beatson, David, Jones, Leonie J., Hopkins, Peter, Allan, Heather M., Glaspole, Ian and Corte, Tamera J. (2018). Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary. Medical Journal of Australia, 208 (2), 82-88. doi: 10.5694/mja17.00799

Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary

2018

Conference Publication

Lysophosphatidic acid drives recruitment and fibroblastic differentiation of mesenchymal stromal cells in chronic lung allograft dysfunction

Sinclair, K. A., Tan, M. E., Sladden, T. M., Hopkins, P. M., O'Sullivan, B. J. and Chambers, D. C. (2018). Lysophosphatidic acid drives recruitment and fibroblastic differentiation of mesenchymal stromal cells in chronic lung allograft dysfunction. 38th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), Nice, France, 11-14 April 2018. Philadelphia, PA, United States: Elsevier . doi: 10.1016/j.healun.2018.01.081

Lysophosphatidic acid drives recruitment and fibroblastic differentiation of mesenchymal stromal cells in chronic lung allograft dysfunction

2018

Journal Article

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

Jo, Helen E., Glaspole, Ian, Goh, Nicole, Hopkins, Peter M. A., Moodley, Yuben, Reynolds, Paul N., Chapman, Sally, Walters, Eugene Haydn, Zappala, Christopher, Allan, Heather, Macansh, Sacha, Grainge, Christopher, Keir, Gregory J., Hayen, Andrew, Henderson, Douglas, Klebe, Sonja, Heinze, Stefan B., Miller, Anne, Rouse, Hannah C., Duhig, Edwina, Cooper, Wendy A., Mahar, Annabelle M., Ellis, Samantha, McCormack, Samuel R., Ng, Bernard, Godbolt, David B. and Corte, Tamera J. (2018). Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. Respirology, 24 (4), 361-368. doi: 10.1111/resp.13427

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry

2017

Journal Article

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

Prasad, Jyotika D., Mahar, Annabelle, Bleasel, Jane, Ellis, Samantha J., Chambers, Daniel C., Lake, Fiona, Hopkins, Peter M. A., Corte, Tamera J., Allan, Heather and Glaspole, Ian N. (2017). The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Respirology, 22 (7), 1459-1472. doi: 10.1111/resp.13163

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

2017

Journal Article

The emerging importance of skeletal muscle function in assessing candidates for transplantation

Walsh, James R., Chambers, Daniel C. and Hopkins, Peter M. A. (2017). The emerging importance of skeletal muscle function in assessing candidates for transplantation. Transplantation, 101 (9), 1967-1968. doi: 10.1097/TP.0000000000001784

The emerging importance of skeletal muscle function in assessing candidates for transplantation

2017

Journal Article

Mesenchymal stromal cell therapy for chronic lung allograft dysfunction: results of a first-in-man study

Chambers, Daniel C., Enever, Debra, Lawrence, Sharon, Sturm, Marian J., Herrmann, Richard, Yerkovich, Stephanie, Musk, Michael and Hopkins, Peter M. A. (2017). Mesenchymal stromal cell therapy for chronic lung allograft dysfunction: results of a first-in-man study. Stem Cells Translational Medicine, 6 (4), 1152-1157. doi: 10.1002/sctm.16-0372

Mesenchymal stromal cell therapy for chronic lung allograft dysfunction: results of a first-in-man study